[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2018 Global Self-administered Drugs Industry Report - History, Present and Future

December 2018 | 141 pages | ID: 2453BE3F8E9PEN
Prof Research

US$ 3,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global market size of Self-administered Drugs is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX million by the end of 2023 with a CAGR of XX% from 2018 to 2023.

There are 3 key segments covered in this report: geography segment, end use/application segment and competitor segment.

For geography segment, regional supply, application-wise and type-wise demand, major players, price is presented from 2013 to 2023. This report coverss following regions:
  • North America
  • South America
  • Asia & Pacific
  • Europe
  • MEA (Middle East and Africa)
The key countries in each region are taken into consideration as well, such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For end use/application segment, this report focuses on the status and outlook for key applications. End users also can be listed.

For competitor segment, the report includes global key players of Self-administered Drugs as well as some small players. The compnaies include:

Abbott Laboratories, Bristol-Myers Squibb, Novartis AG, Eli Lilly and Company, Gilead Sciences, Antares Pharma et al.

The information for each competitor includes:
  • Company Profile
  • Main Business Information
  • SWOT Analysis
  • Sales, Revenue, Price and Gross Margin
  • Market Share
We also can offer customized report to fulfill special requirements of our clients.
CHAPTER 1 EXECUTIVE SUMMARY

CHAPTER 2 ABBREVIATION AND ACRONYMS

CHAPTER 3 PREFACE

3.1 Research Scope
3.2 Research Methodology
  3.2.1 Data Collection
  3.2.2 Data Analysis
  3.2.3 Data Validation
3.3 Research Sources
  3.3.1 Primary Sources
  3.3.2 Secondary Sources
  3.3.3 Assumptions

CHAPTER 4 MARKET LANDSCAPE

4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users

CHAPTER 5 MARKET TREND ANALYSIS

5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats

CHAPTER 6 INDUSTRY CHAIN ANALYSIS

6.1 Upstream/Suppliers Analysis
6.2 Self-administered Drugs Analysis
  6.2.1 Technology Analysis
  6.2.2 Cost Analysis
  6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users

CHAPTER 7 LATEST MARKET DYNAMICS

7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics

CHAPTER 8 TRADING ANALYSIS

8.1 Export of Self-administered Drugs by Region
8.2 Import of Self-administered Drugs by Region
8.3 Balance of Trade

CHAPTER 9 HISTORICAL AND CURRENT SELF-ADMINISTERED DRUGS MARKET IN NORTH AMERICA (2013-2018)

9.1 Self-administered Drugs Supply
9.2 Self-administered Drugs Demand by End Use
9.3 Competition by Players/Suppliers
9.4 Type Segmentation and Price
9.5 Key Countries Analysis

CHAPTER 10 HISTORICAL AND CURRENT SELF-ADMINISTERED DRUGS MARKET IN SOUTH AMERICA (2013-2018)

10.1 Self-administered Drugs Supply
10.2 Self-administered Drugs Demand by End Use
10.3 Competition by Players/Suppliers
10.4 Type Segmentation and Price
10.5 Key Countries Analysis

CHAPTER 11 HISTORICAL AND CURRENT SELF-ADMINISTERED DRUGS MARKET IN ASIA & PACIFIC (2013-2018)

11.1 Self-administered Drugs Supply
11.2 Self-administered Drugs Demand by End Use
11.3 Competition by Players/Suppliers
11.4 Type Segmentation and Price
11.5 Key Countries Analysis

CHAPTER 12 HISTORICAL AND CURRENT SELF-ADMINISTERED DRUGS MARKET IN EUROPE (2013-2018)

12.1 Self-administered Drugs Supply
12.2 Self-administered Drugs Demand by End Use
12.3 Competition by Players/Suppliers
12.4 Type Segmentation and Price
12.5 Key Countries Analysis

CHAPTER 13 HISTORICAL AND CURRENT SELF-ADMINISTERED DRUGS MARKET IN MEA (2013-2018)

13.1 Self-administered Drugs Supply
13.2 Self-administered Drugs Demand by End Use
13.3 Competition by Players/Suppliers
13.4 Type Segmentation and Price
13.5 Key Countries Analysis

CHAPTER 14 SUMMARY FOR GLOBAL SELF-ADMINISTERED DRUGS MARKET (2013-2018)

14.1 Self-administered Drugs Supply
14.2 Self-administered Drugs Demand by End Use
14.3 Competition by Players/Suppliers
14.4 Type Segmentation and Price

CHAPTER 15 GLOBAL SELF-ADMINISTERED DRUGS MARKET FORECAST (2019-2023)

15.1 Self-administered Drugs Supply Forecast
15.2 Self-administered Drugs Demand Forecast
15.3 Competition by Players/Suppliers
15.4 Type Segmentation and Price Forecast

CHAPTER 16 COMPANY PROFILE(ABBOTT LABORATORIES, BRISTOL-MYERS SQUIBB, NOVARTIS AG, ELI LILLY AND COMPANY, GILEAD SCIENCES, ANTARES PHARMA ET AL.)

16.1 Company A
  16.1.1 Company Profile
  16.1.2 Main Business and Self-administered Drugs Information
  16.1.3 SWOT Analysis of Company A
  16.1.4 Company A Self-administered Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
16.2 Company B
  16.2.1 Company Profile
  16.2.2 Main Business and Self-administered Drugs Information
  16.2.3 SWOT Analysis of Company B
  16.2.4 Company B Self-administered Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
16.3 Company C
  16.3.1 Company Profile
  16.3.2 Main Business and Self-administered Drugs Information
  16.3.3 SWOT Analysis of Company C
  16.3.4 Company C Self-administered Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
16.4 Company D
  16.4.1 Company Profile
  16.4.2 Main Business and Self-administered Drugs Information
  16.4.3 SWOT Analysis of Company D
  16.4.4 Company D Self-administered Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
16.5 Company E
  16.5.1 Company Profile
  16.5.2 Main Business and Self-administered Drugs Information
  16.5.3 SWOT Analysis of Company E
  16.5.4 Company E Self-administered Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
16.6 Company F
  16.6.1 Company Profile
  16.6.2 Main Business and Self-administered Drugs Information
  16.6.3 SWOT Analysis of Company F
  16.6.4 Company F Self-administered Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
16.7 Company G
  16.7.1 Company Profile
  16.7.2 Main Business and Self-administered Drugs Information
  16.7.3 SWOT Analysis of Company G
  16.7.4 Company G Self-administered Drugs Sales, Revenue, Price and Gross Margin (2013-2018)

TABLES AND FIGURES

Table Abbreviation and Acronyms List
Table Research Scope of Self-administered Drugs Report
Table Primary Sources of Self-administered Drugs Report
Table Secondary Sources of Self-administered Drugs Report
Table Major Assumptions of Self-administered Drugs Report
Figure Self-administered Drugs Picture
Table Self-administered Drugs Classification
Table Self-administered Drugs Applications List
Table Drivers of Self-administered Drugs Market
Table Restraints of Self-administered Drugs Market
Table Opportunities of Self-administered Drugs Market
Table Threats of Self-administered Drugs Market
Table Key Raw Material of Self-administered Drugs and Its Suppliers
Table Key Technologies of Self-administered Drugs
Table Cost Structure of Self-administered Drugs
Table Market Channel of Self-administered Drugs
Table Self-administered Drugs Application and Key End Users List
Table Latest News of Self-administered Drugs Industry
Table Recently Merger and Acquisition List of Self-administered Drugs Industry
Table Recently Planned/Future Project List of Self-administered Drugs Industry
Table Policy Dynamics Update of Self-administered Drugs Industry
Table 2013-2023 Export of Self-administered Drugs by Region
Table 2013-2023 Import of Self-administered Drugs by Region
Table 2013-2023 Balance of Trade of Self-administered Drugs
Figure 2013 2018 and 2023 Global Trade Map of Self-administered Drugs
Table 2013-2018 North America Supply of Self-administered Drugs
Figure 2013-2018 North America Self-administered Drugs Supply and GAGR
Table 2013-2018 North America Self-administered Drugs Downstream Demand List
Figure 2013-2018 North America Self-administered Drugs Downstream Demand and CAGR
Figure 2013 Major Players Market Share in North America
Figure 2018 Major Players Market Share in North America
Table 2013-2018 North America Self-administered Drugs Demand by Type
Figure 2013-2018 North America Self-administered Drugs Price
Table 2013-2018 Key Countries Supply of Self-administered Drugs in North America
Table 2013-2018 Key Countries Market Share of Supply in North America
Table 2013-2018 Key Countries Demand of Self-administered Drugs in North America
Table 2013-2018 Key Countries Market Share of Demand in North America
Table 2013-2018 South America Supply of Self-administered Drugs
Figure 2013-2018 South America Self-administered Drugs Supply and GAGR
Table 2013-2018 South America Self-administered Drugs Downstream Demand List
Figure 2013-2018 South America Self-administered Drugs Downstream Demand and CAGR
Figure 2013 Major Players Market Share in South America
Figure 2018 Major Players Market Share in South America
Table 2013-2018 South America Self-administered Drugs Demand by Type
Figure 2013-2018 South America Self-administered Drugs Price
Table 2013-2018 Key Countries Supply of Self-administered Drugs in South America
Table 2013-2018 Key Countries Market Share of Supply in South America
Table 2013-2018 Key Countries Demand of Self-administered Drugs in South America
Table 2013-2018 Key Countries Market Share of Demand in South America
Table 2013-2018 Asia & Pacific Supply of Self-administered Drugs
Figure 2013-2018 Asia & Pacific Self-administered Drugs Supply and GAGR
Table 2013-2018 Asia & Pacific Self-administered Drugs Downstream Demand List
Figure 2013-2018 Asia & Pacific Self-administered Drugs Downstream Demand and CAGR
Figure 2013 Major Players Market Share in Asia & Pacific
Figure 2018 Major Players Market Share in Asia & Pacific
Table 2013-2018 Asia & Pacific Self-administered Drugs Demand by Type
Figure 2013-2018 Asia & Pacific Self-administered Drugs Price
Table 2013-2018 Key Countries Supply of Self-administered Drugs in Asia & Pacific
Table 2013-2018 Key Countries Market Share of Supply in Asia & Pacific
Table 2013-2018 Key Countries Demand of Self-administered Drugs in Asia & Pacific
Table 2013-2018 Key Countries Market Share of Demand in Asia & Pacific
Table 2013-2018 Europe Supply of Self-administered Drugs
Figure 2013-2018 Europe Self-administered Drugs Supply and GAGR
Table 2013-2018 Europe Self-administered Drugs Downstream Demand List
Figure 2013-2018 Europe Self-administered Drugs Downstream Demand and CAGR
Figure 2013 Major Players Market Share in Europe
Figure 2018 Major Players Market Share in Europe
Table 2013-2018 Europe Self-administered Drugs Demand by Type
Figure 2013-2018 Europe Self-administered Drugs Price
Table 2013-2018 Key Countries Supply of Self-administered Drugs in Europe
Table 2013-2018 Key Countries Market Share of Supply in Europe
Table 2013-2018 Key Countries Demand of Self-administered Drugs in Europe
Table 2013-2018 Key Countries Market Share of Demand in Europe
Table 2013-2018 MEA Supply of Self-administered Drugs
Figure 2013-2018 MEA Self-administered Drugs Supply and GAGR
Table 2013-2018 MEA Self-administered Drugs Downstream Demand List
Figure 2013-2018 MEA Self-administered Drugs Downstream Demand and CAGR
Figure 2013 Major Players Market Share in MEA
Figure 2018 Major Players Market Share in MEA
Table 2013-2018 MEA Self-administered Drugs Demand by Type
Figure 2013-2018 MEA Self-administered Drugs Price
Table 2013-2018 Key Countries Supply of Self-administered Drugs in MEA
Table 2013-2018 Key Countries Market Share of Supply in MEA
Table 2013-2018 Key Countries Demand of Self-administered Drugs in MEA
Table 2013-2018 Key Countries Market Share of Demand in MEA
Table 2013-2018 Global Supply of Self-administered Drugs by Region
Figure 2013-2018 Global Supply and CAGR of Self-administered Drugs by Region
Table 2013-2018 Global Self-administered Drugs Downstream Demand List by Region
Figure 2013-2018 Global Self-administered Drugs Downstream Demand and CAGR by Region
Figure 2013 Global Major Players Market Share
Figure 2018 Global Major Players Market Share
Table 2013-2018 Global Self-administered Drugs Type-wise Demand by Region
Figure 2013-2018 Global Self-administered Drugs Price
Table Main Business and Self-administered Drugs Information of Company A
Table SWOT Analysis of Company A
Table 2013-2018 Company A Self-administered Drugs Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company A Self-administered Drugs Sales Revenue and Growth Rate
Figure 2013-2018 Company A Self-administered Drugs Market Share
Table Main Business and Self-administered Drugs Information of Company B
Table SWOT Analysis of Company B
Table 2013-2018 Company B Self-administered Drugs Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company B Self-administered Drugs Sales Revenue and Growth Rate
Figure 2013-2018 Company B Self-administered Drugs Market Share
Table Main Business and Self-administered Drugs Information of Company C
Table SWOT Analysis of Company C
Table 2013-2018 Company C Self-administered Drugs Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company C Self-administered Drugs Sales Revenue and Growth Rate
Figure 2013-2018 Company C Self-administered Drugs Market Share
Table Main Business and Self-administered Drugs Information of Company D
Table SWOT Analysis of Company D
Table 2013-2018 Company D Self-administered Drugs Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company D Self-administered Drugs Sales Revenue and Growth Rate
Figure 2013-2018 Company D Self-administered Drugs Market Share
Table Main Business and Self-administered Drugs Information of Company E
Table SWOT Analysis of Company E
Table 2013-2018 Company E Self-administered Drugs Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company E Self-administered Drugs Sales Revenue and Growth Rate
Figure 2013-2018 Company E Self-administered Drugs Market Share
Table Main Business and Self-administered Drugs Information of Company F
Table SWOT Analysis of Company F
Table 2013-2018 Company F Self-administered Drugs Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company F Self-administered Drugs Sales Revenue and Growth Rate
Figure 2013-2018 Company F Self-administered Drugs Market Share
Table Main Business and Self-administered Drugs Information of Company G
Table SWOT Analysis of Company G
Table 2013-2018 Company G Self-administered Drugs Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company G Self-administered Drugs Sales Revenue and Growth Rate
Figure 2013-2018 Company G Self-administered Drugs Market Share


More Publications